$NERV – How big could it be?

Minerva Neurosciences Inc. are a company who just submitted a New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia.

24 million people with Schizophrenia in the world.

Successful trials of this drug: http://ir.minervaneurosciences.com/news-releases/news-release-details/minerva-neurosciences-submits-new-drug-application-fda

If it were to be FDA approved and commercialized, does anyone have experience with what this might do to the stock price?

Closed at $7.51 yesterday.

Thanks!